Answers are grounded in this paper and cite their sources.
Randomized trial compares visual outcomes and satisfaction in patients with cataracts using two types of IOLs, suggesting benefits of PanOptix lenses.
PURPOSE: To compare visual and patient-reported outcomes in patients with cataracts bilaterally implanted with PanOptix or Synergy intraocular lenses (IOLs). SETTINGS: 5 sites in the United States. DESIGN: Prospective, parallel-arm randomized patient-masked and examiner-masked clinical study. METHODS: Adult patients with cataract (≥22 years) were randomized (1:1) to receive bilateral PanOptix or Synergy IOL implantation. Study endpoints: binocular uncorrected (UDVA) and corrected distance visual acuity (CDVA) (logMAR) at distance, intermediate (60 cm), and near (40 and 33 cm); defocus curve; patient-reported visual disturbances, spectacle independence, and visual satisfaction using questionnaires at 6 months; and binocular contrast sensitivity at 3 months. RESULTS: At 6 months, PanOptix (n = 138) was noninferior to Synergy (n = 138) IOLs for photopic binocular UDVA and CDVA at all tested distances ( P < .05). Mesopic intermediate and near VA showed a similar trend. Defocus curves showed that both IOLs provided VA of ≤0.1 logMAR from -2.50 to +0.50 diopters (D) and <0.2 logMAR at -3.00 D. A significantly lower proportion of patients with PanOptix (vs Synergy) experienced starbursts and glare ( P < .05). Most patients in both groups reported never/rarely needing spectacles to see and high satisfaction with vision. Both IOLs provided similar binocular contrast sensitivity at 3 months under photopic and mesopic conditions. CONCLUSIONS: PanOptix IOLs provided a similar full range of vision, spectacle independence, and contrast sensitivity, but superior tolerance to glare and starbursts, compared with Synergy IOLs.
No takes yet. Share an insight, caveat, or question.
Modi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: